Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 08, 2022

BUY
$13.18 - $19.41 $274,144 - $403,728
20,800 Added 208.0%
30,800 $419,000
Q1 2022

May 16, 2022

BUY
$14.73 - $35.25 $114,894 - $274,950
7,800 Added 354.55%
10,000 $196,000
Q4 2021

Feb 14, 2022

SELL
$33.72 - $48.22 $809,280 - $1.16 Million
-24,000 Reduced 91.6%
2,200 $75,000
Q3 2021

Nov 15, 2021

BUY
$49.26 - $74.5 $733,974 - $1.11 Million
14,900 Added 131.86%
26,200 $1.43 Million
Q2 2021

Aug 16, 2021

BUY
$56.91 - $127.53 $512,189 - $1.15 Million
9,000 Added 391.3%
11,300 $830,000
Q1 2021

May 17, 2021

BUY
$79.79 - $126.29 $183,517 - $290,467
2,300 New
2,300 $210,000

Others Institutions Holding CVAC

About CureVac N.V.


  • Ticker CVAC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,467,008
  • Market Cap $716M
  • Description
  • CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...
More about CVAC
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.